HOME >> MEDICINE >> NEWS
Researchers examine the use of antiretroviral therapy among injection drug users with HIV infection: Study suggests addiction treatment and health care contribute to HAART enrollment

Over 40 percent of injection drug users with HIV that are eligible for the highly active antiretroviral therapy (HAART) fail to undergo the treatment, according to a study conducted by the Johns Hopkins Bloomberg School of Public Health.

The HAART regimen, or "drug cocktail," is a combination of several antiretroviral drugs that can dramatically reduce the levels of HIV in the body and slow the progression to AIDS. The study, which appears in the September 2001 issue of the journal, AIDS, suggests that injection drug use is a major impediment to initiating HAART therapy, while methadone addiction treatment among men, health insurance, and access to regular health care were factors associated with increased HAART use.

"Injection drug users directly or indirectly account for nearly half of all the people infected with HIV in the United States each year, and they are a population that could certainly benefit from HAART use.

In addition to making people with HIV feel better, HAART has also been shown to make them less infectious to others by reducing their viral load, so there is a real benefit to the public," says lead author David D. Celentano, ScD, MHS, professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.

"Over the years, we've seen an increase in the number of injection drug users undergoing HAART, but a large number still do not use the therapy. It is important to understand the factors involved in why drug users choose or do not choose this therapy. Our study examines some of the factors that contribute to HAART use among injection drug users with HIV," adds Dr. Celentano.

For the study, researchers examined 528 HIV-infected injection drug users living in Baltimore, Maryland between 1996 and 1999. All of the study's participants were originally part of a larger long-term study of AIDS and injection drug users known as AIDS Links to Intravenous Experience (ALIVE). In addition, all of the partic
'"/>

Contact: Tim Parsons or Ming Tai
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
25-Sep-2001


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/16/2019)... ... March 16, 2019 , ... Blood Flow ... Ligament (ACL) reconstruction patients often face bone and muscle loss immediately following the ... note that combining blood flow restriction (BFR) therapy with traditional rehabilitation efforts may ...
(Date:3/15/2019)... ... March 15, 2019 , ... ... announced the launch of its newly designed healthcare website, SMG3RX.com. Integrating a vibrant ... easily find a solution that fits their needs. , “We are thrilled to ...
(Date:3/15/2019)... ... March 15, 2019 , ... Esteemed Marietta dentist Dr. Michael ... Dental Assisting . The private dental assistant school is recognized as one of the ... a position within sixty days of graduation. Assisting 101 - School of Dental Assisting ...
(Date:3/15/2019)... ... 15, 2019 , ... The National Association of Chain Drug ... seven-day supply the initial prescriptions of opioids for acute pain – a move ... for prescribing opioids. , U.S. Sen. Kirsten Gillibrand (D-NY) and U.S. Sen. Cory ...
(Date:3/14/2019)... ... March 14, 2019 , ... When:    Wednesday, ... at Midtown - 1900 Long Beach Blvd., Long Beach, CA 90806 , What:    Los ... Housing, county and city officials, and other partners to celebrate the start of ...
Breaking Medicine News(10 mins):
(Date:3/14/2019)... ... 2019 , ... AxioMed announced today the issuance ... approval was received as a result of an accredited Notified Body assessment of ... clinical data regarding the viscoelastic AxioMed technology. , AxioMed first received CE ...
(Date:3/13/2019)... ... March 13, 2019 , ... Guard RFID Solutions Inc., a ... Tag (PT-3), a small and lightweight wearable RFID tag with a user-activated push ... in hazardous industrial environments. , “We have developed our most versatile tag to ...
(Date:3/13/2019)... ... March 13, 2019 , ... ... FocusOne Solutions ® has been recognized for its longevity as one of the ... has earned the Sustained Excellence Award which recognizes employers that have been ...
Breaking Medicine Technology:
Cached News: